Acadia Pharmaceuticals (ACAD) Goodwill & Intangibles (2016 - 2026)
Acadia Pharmaceuticals has reported Goodwill & Intangibles over the past 9 years, most recently at $108.9 million for Q4 2025.
- For Q4 2025, Goodwill & Intangibles fell 9.09% year-over-year to $108.9 million; the TTM value through Dec 2025 reached $108.9 million, down 9.09%, while the annual FY2025 figure was $108.9 million, 9.09% down from the prior year.
- Goodwill & Intangibles for Q4 2025 was $108.9 million at Acadia Pharmaceuticals, down from $111.6 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $119.8 million in Q4 2024 and troughed at $369000.0 in Q2 2021.
- A 4-year average of $84.0 million and a median of $106.7 million in 2024 define the central range for Goodwill & Intangibles.
- Biggest five-year swings in Goodwill & Intangibles: plummeted 80.01% in 2021 and later surged 82.9% in 2024.
- Year by year, Goodwill & Intangibles stood at $369000.0 in 2021, then soared by 17647.97% to $65.5 million in 2023, then soared by 82.9% to $119.8 million in 2024, then decreased by 9.09% to $108.9 million in 2025.
- Business Quant data shows Goodwill & Intangibles for ACAD at $108.9 million in Q4 2025, $111.6 million in Q3 2025, and $114.3 million in Q2 2025.